Total anatomical reconstruction during robot-assisted radical prostatectomy: focus on urinary continence recovery and related complications after 1000 procedures.


Journal

BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 26 2 2019
medline: 19 5 2020
entrez: 26 2 2019
Statut: ppublish

Résumé

To present the functional and oncological outcomes after ≥1 year of follow-up, following an experience of >1000 robot-assisted radical prostatectomies (RARPs) with our standardised total anatomical reconstruction (TAR) technique. To evaluate which factors influence postoperative continence recovery in order to obtain a nomogram to predict the risk of postoperative urinary incontinence (UI). The enrolment phase began in June 2013 and ended in May 2017. Patients were prospectively included in the study with the following inclusion criteria: (i) localised prostate cancer (clinical stages cT1-3, cN0, cM0); (ii) indication for RP; and (iii) preoperative multiparametric prostate magnetic resonance imaging. All patients underwent RARP with the TAR technique done at the end of the demolitive phase. The continence rates were assessed at 24 h, and 1, 4, 12, 24 and 48 weeks after catheter removal. Patients were defined as continent if they answered 'zero pad' or 'one safety pad' per day. A logistic regression model was used to evaluate the potential impact of some pre- and intraoperative factors on postoperative urinary continence recovery. Model discrimination was assessed using an area under (AUC) the receiver operating characteristic (ROC) curve. A nomogram to predict the risk of postoperative UI after RARP with the TAR technique was generated based on the logistic model. In all, 1008 patients were enrolled in our study. At 24 h, and 1, 4, 12, 24 and 48 weeks after catheter removal, 621 (61.61%), 594 (58.93%), 803 (79.66%), 912 (90.48%), 950 (94.25%) and 956 (94.84%) patients were continent, respectively. In the logistic regression model, the variables analysed had a higher impact on continence recovery at 4 and 12 weeks. At 4 weeks, the postoperative odds of urinary continence recovery increased with the absence of diabetes [odds ratio (OR) 2.76, 95% confidence interval (CI) 1.41-5.41] and D'Amico low vs high risk (OR 2.01, 95% CI 1.01-3.99). At 12 weeks, urinary continence increased with the absence of diabetes (OR 3.01, 95% CI 1.23-7.35), D'Amico low vs high risk (OR 4.04, 95% CI 1.56-10.47), and D'Amico intermediate vs high risk (OR 3.33, 95% CI 1.66-6.70). ROC curves were drawn and an AUC value of 61.9% (95% CI 57.49-66.36) at 4 weeks and 63.8% (95% CI 58.03-69.65) at 12 weeks were computed. Based on these parameters, two nomograms (at 4 and 12 weeks postoperatively) were generated. The TAR technique conferred excellent results in the early recovery of urinary continence. Two nomograms were created, to predict preoperatively the postoperative odds of urinary continence recovery at 4 and 12 weeks after RARP by integrating the presence of diabetes and D'Amico risk classification.

Identifiants

pubmed: 30801887
doi: 10.1111/bju.14716
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

477-486

Informations de copyright

© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.

Références

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7-30
Hamdy FC, Donovan JL, Lane JA et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 2016; 375: 1415-24
Sridhar AN, Abozaid M, Rajan P et al. Surgical techniques to optimize early urinary continence recovery post robot assisted radical prostatectomy for prostate cancer. Curr Urol Rep 2017; 18: 71. https://doi.org/10.1007/s11934-017-0717-4.
Jazayeri SB, Weissman B, Samadi DB. Outcomes following robotic-assisted laparoscopic prostatectomy: Pentafecta and Trifecta achievements. Minerva Urol Nefrol 2018; 70: 66-73
Ficarra V, Novara G, Rosen RC et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2012; 62: 405-17
Ficarra V, Novara G, Ahlering TE et al. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol 2012; 62: 418-30
Novara G, Ficarra V, Mocellin S et al. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol 2012; 62: 382-404
Porpiglia F, Fiori C, Bertolo R et al. Five-year outcomes for a prospective randomised controlled trial comparing laparoscopic and robot-assisted radical prostatectomy. Eur Urol Focus 2018; 4: 80-6
O'Neil B, Koyama T, Alvarez J et al. The comparative harms of open and robotic prostatectomy in population based samples. J Urol 2016; 195: 321-9
Lavigueur-Blouin H, Noriega AC, Valdivieso R et al. Predictors of early continence following robot-assisted radical prostatectomy. Can Urol Assoc J 2015; 9: e93-7
Manfredi M, Fiori C, Amparore D, Checcucci E, Porpiglia F. Technical details to achieve perfect early continence after radical prostatectomy. Minerva Chir 2019; 74: 63-77
Porpiglia F, Bertolo R, Manfredi M et al. Total anatomical reconstruction during robot-assisted radical prostatectomy: implications on early recovery of urinary continence. Eur Urol 2016; 69: 485-95
Montorsi F, Wilson TG, Rosen RC et al. Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. Eur Urol 2012; 62: 368-81
Menon M, Dalela D, Jamil M et al. Functional recovery, oncologic outcomes and postoperative complications after robot-assisted radical prostatectomy: an evidence-based analysis comparing the Retzius sparing and standard approaches. J Urol 2018; 199: 1210-7
Cookson MS, Aus G, Burnett AL et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association prostate guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 2007; 177: 540-5
Rossanese M, Crestani A, Palumbo V et al. Time of catheterization as an independent predictor of early urinary continence recovery after radical prostatectomy. Minerva Urol Nefrol 2018; 70: 401-7
Yanagida T, Koguchi T, Hata J et al. Current techniques to improve outcomes for early return of urinary continence following robot-assisted radical prostatectomy. Fukushima J Med Sci 2014; 60: 1-13
Porreca A, D'agostino D, Dandrea M et al. Bidirectional barbed suture for posterior musculofascial reconstruction and knotless vesicourethral anastomosis during robot-assisted radical prostatectomy. Minerva Urol Nefrol 2018; 70: 319-25
Tan G, Srivastava A, Grover S et al. Optimizing vesicourethral anastomosis healing after robot-assisted laparoscopic radical prostatectomy: lessons learned from three techniques in 1900 patients. J Endourol 2010; 24: 1975-83
Gautam G, Rocco B, Patel VR, Zorn KC. Posterior rhabdosphincter reconstruction during robot-assisted radical prostatectomy: critical analysis of techniques and outcomes. Urology 2010; 76: 734-41
Hurtes X, Rouprêt M, Vaessen C et al. Anterior suspension combined with posterior reconstruction during robot-assisted laparoscopic prostatectomy improves early return of UC: a prospective randomized multicentre trial. BJU Int 2012; 110: 875-83
Sammon JD, Muhletaler F, Peabody JO, Diaz-Insua M, Satyanaryana R, Menon M. Long-term functional urinary outcomes comparing single- vs double-layer urethrovesical anastomosis: two year follow-up of a two-group parallel randomized controlled trial. Urology 2010; 76: 1102-7
Menon M, Muhletaler F, Campos M, Peabody JO. Assessment of early continence after reconstruction of the periprostatic tissues in patients undergoing computer assisted (robotic) prostatectomy: results of a 2 group parallel randomized controlled trial. J Urol 2008; 180: 1018-23
Koliakos N, Mottrie A, Buffi N, De Naeyer G, Willemsen P, Fonteyne E. Posterior and anterior fixation of the urethra during robotic prostatectomy improves early continence rates. Scand J Urol Nephrol 2010; 44: 5-10
Tewari A, Jhaveri J, Rao S et al. Total reconstruction of the vesico-urethral junction. BJU Int 2008; 101: 871-7
Wu YP, Xu N, Wang ST et al. The efficacy and feasibility of total reconstruction versus nontotal reconstruction of the pelvic floor on short-term and long-term urinary continence rates after radical prostatectomy: a meta-analysis. World J Surg Oncol 2017; 15: 228. https://doi.org/10.1186/s12957-017-1296-z
Galfano A, Ascione A, Grimaldi S, Petralia G, Strada E, Bocciardi AM. A new anatomic approach for robot-assisted laparoscopic prostatectomy: a feasibility study for completely intrafascial surgery. Eur Urol 2010; 58: 457-61
Dalela D, Jeong W, Prasad MA et al. A pragmatic randomized controlled trial examining the impact of the Retzius-sparing approach on early urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2017; 72: 677-85
Stonier T, Simson N, Davis J, Challacombe B. Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) vs standard RARP: it's time for critical appraisal. BJU Int 2019; 123: 5-7
O'Callaghan ME, Raymond E, Campbell J et al. Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity. Prostate Cancer Prostatic Dis 2017; 20: 378-88
Matsushita K, Kent MT, Vickers AJ et al. Preoperative predictive model of recovery of urinary continence after radical prostatectomy. BJU Int 2015; 116: 577-83
Jeong SJ, Yeon JS, Lee JK et al. Development and validation of nomograms to predict the recovery of urinary continence after radical prostatectomy: comparisons between immediate, early, and late continence. World J Urol 2014; 32: 437-44
Tienza A, Hevia M, Benito A, Pascual JI, Zudaire JJ, Robles JE. MRI factors to predict urinary incontinence after retropubic/laparoscopic radical prostatectomy. Int Urol Nephrol 2015; 47: 1343-9
Porpiglia F, Bertolo R, Fiori C, Manfredi M, De Cillis S, Geuna S. Chitosan membranes applied on the prostatic neurovascular bundles after nerve-sparing robot-assisted radical prostatectomy: a phase II study. BJU Int 2018; 121: 472-8
Porpiglia F, Manfredi M, Checcucci E et al. Use of chitosan membranes after nerve-sparing radical prostatectomy improves early recovery of sexual potency: results of a comparative study. BJU Int 2019; 123: 421-28
Geuna S, Muratori L, Fregnan F, Manfredi M, Bertolo R, Porpiglia F. Strategies to improve nerve regeneration after radical prostatectomy: a narrative review. Minerva Urol Nefrol 2018; 70: 546-58

Auteurs

Matteo Manfredi (M)

Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Enrico Checcucci (E)

Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Cristian Fiori (C)

Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Diletta Garrou (D)

Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Roberta Aimar (R)

Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Daniele Amparore (D)

Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Stefano De Luca (S)

Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Sabrina Bombaci (S)

Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Ilaria Stura (I)

Department of Public Health and Pediatric Sciences, School of Medicine, University of Turin, Turin, Italy.

Giuseppe Migliaretti (G)

Department of Public Health and Pediatric Sciences, School of Medicine, University of Turin, Turin, Italy.

Francesco Porpiglia (F)

Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH